Clinical Trial

Comparison of Patients With COPD and PRISM

Recruiting
View on ClinicalTrials.gov →
Summary
COPD is a preventable and treatable lung disease characterized by persistent and progressive airflow limitation. PRISm, on the other hand, is a spirometry pattern that does not meet COPD diagnostic criteria despite symptoms and functional impairments, but requires maintenance. PRISm can predispose to the development of COPD and exacerbations, and can reduce exercise capacity by reducing respiratory function and oxygen consumption. There are no studies in the literature comparing respiratory muscle strength, peripheral muscle strength, and oxygenation in PRISm, COPD, and healthy individuals. Therefore, this study aimed to evaluate these parameters and compare them with healthy individuals.
Trial Details
NCT Number NCT07249567
Lead Sponsor Karabuk University
Conditions COPD
Enrollment 60 participants
Start Date 2025-10-05
Primary Completion 2026-09-05 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-25